AbbVie (NYSE: ABBV) is a US drugmaker which manufactures the world's top-selling medicine Humira. From 2016, Humira, which constitutes nearly 60% of AbbVie's income, will no longer be protected by patent.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze